{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:18:27Z","timestamp":1788218307584,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ibneur.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:28:14Z","timestamp":1730971694000},"page":"423-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer\u2019s diseases"],"prefix":"10.1016","volume":"17","author":[{"given":"Sookhee","family":"Bang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Kuen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.ibneur.2024.11.005_bib1","doi-asserted-by":"crossref","first-page":"19195","DOI":"10.1074\/jbc.274.27.19195","article-title":"Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site","volume":"274","author":"Alvarez-Fernandez","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2024.11.005_bib2","article-title":"Tau Phosphorylation by GSK3 in Different Conditions","volume":"2012","author":"Avila","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2005.03181.x","article-title":"Sequestosome 1\/p62 shuttles polyubiquitinated tau for proteasomal degradation","volume":"94","author":"Babu","year":"2005","journal-title":"J. Neurochem"},{"issue":"9","key":"10.1016\/j.ibneur.2024.11.005_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ibneur.2024.11.005_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136298","article-title":"Human serum albumin fusion protein as therapeutics for targeting amyloid beta in Alzheimer's diseases","volume":"767","author":"Bang","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2024.11.005_bib6","unstructured":"Bang, S., Song, J.K., Shin, S.-W., Lee, K.H., Lee, H.J., inventors; L & J Bio Co., Ltd., assignee. Methods of decreasing Amyloid Beta (A\u03b2) plaque deposition and Hyperphosphorylated Tau plaque deposition in Alzheimer\u2019s disease using a Cystatin C fusion protein. United States Patent US 12,115,212 B2. 2024 Oct. 15."},{"issue":"24","key":"10.1016\/j.ibneur.2024.11.005_bib7","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M112.446070","article-title":"Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease","volume":"288","author":"Basurto-Islas","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00401-011-0908-x","article-title":"An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide","volume":"123","author":"Bolognin","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.ibneur.2024.11.005_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.ibneur.2024.11.005_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.ibneur.2024.11.005_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett","year":"1993","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12692","article-title":"Interplay of pathogenic forms of human tau with different autophagic pathways","volume":"17","author":"Caballero","year":"2018","journal-title":"Aging Cell"},{"issue":"16","key":"10.1016\/j.ibneur.2024.11.005_bib13","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/j.febslet.2006.06.021","article-title":"Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine","volume":"580","author":"Chohan","year":"2006","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.ibneur.2024.11.005_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286523","article-title":"Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice","volume":"18","author":"Davidowitz","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ibneur.2024.11.005_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","article-title":"Proteasomal and Autophagic Degradation Systems","volume":"86","author":"Dikic","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.ibneur.2024.11.005_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molcel.2015.05.031","article-title":"Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates","volume":"59","author":"Egan","year":"2015","journal-title":"Mol. Cell."},{"issue":"5","key":"10.1016\/j.ibneur.2024.11.005_bib17","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1046\/j.1471-4159.2000.0752155.x","article-title":"Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations","volume":"75","author":"Goedert","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2024.11.005_bib18","first-page":"921","article-title":"Phosphoprotein phosphatase activities in Alzheimer disease. J. Neurochem","volume":"61","author":"Gong","year":"1993"},{"issue":"13","key":"10.1016\/j.ibneur.2024.11.005_bib19","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ibneur.2024.11.005_bib20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1042\/BST0380962","article-title":"Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial","volume":"38","author":"Iqbal","year":"2010","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.ibneur.2024.11.005_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","article-title":"Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform","volume":"24","author":"Ishihara","year":"1999","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.ibneur.2024.11.005_bib22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jalz.2016.06.006","article-title":"Therapeutic strategies for the treatment of tauopathies: Hopes and challenges","volume":"12","author":"Khanna","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.ibneur.2024.11.005_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105584","article-title":"PP2A inhibitor SET promotes mTORC1 and Bmi1 signaling through Akt activation and maintains the colony-formation ability of cancer cells","volume":"300","author":"Kohyanagi","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2024.11.005_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.793328","article-title":"Selective Autophagy Receptor p62\/SQSTM1, a Pivotal Player in Stress and Aging","volume":"10","author":"Kumar","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"Pt 5","key":"10.1016\/j.ibneur.2024.11.005_bib26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/brain\/awp059","article-title":"Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study","volume":"132","author":"Lace","year":"2009","journal-title":"Brain"},{"issue":"25","key":"10.1016\/j.ibneur.2024.11.005_bib27","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1073\/pnas.0602913103","article-title":"An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice","volume":"103","author":"Le Corre","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ibneur.2024.11.005_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.ibneur.2024.11.005_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ibneur.2024.11.005_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40035-018-0139-3","article-title":"Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis","volume":"7","author":"Li","year":"2018","journal-title":"Transl. Neurodegener."},{"issue":"19","key":"10.1016\/j.ibneur.2024.11.005_bib31","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.1074\/jbc.271.19.11059","article-title":"The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A","volume":"271","author":"Li","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ibneur.2024.11.005_bib32","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.ibneur.2024.11.005_bib33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.neurobiolaging.2007.03.012","article-title":"Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms","volume":"29","author":"Liu","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.ibneur.2024.11.005_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neurobiolaging.2012.06.026","article-title":"PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins","volume":"34","author":"Magnaudeix","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.ibneur.2024.11.005_bib35","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.ibneur.2024.11.005_bib36","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.celrep.2018.11.042","article-title":"ULK1 O-GlcNAcylation is crucial for activating VPS34 via ATG14L during autophagy initiation","volume":"25","author":"Pyo","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.ibneur.2024.11.005_bib37","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-2010-1317","article-title":"PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta","volume":"19","author":"Qian","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1471-4159.2008.05340.x","article-title":"Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration","volume":"106","author":"Ramesh Babu","year":"2008","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in neurodegenerative diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5825","key":"10.1016\/j.ibneur.2024.11.005_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ibneur.2024.11.005_bib41","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.neurobiolaging.2013.03.015","article-title":"Tau phosphorylation affects its axonal transport and degradation","volume":"34","author":"Rodriguez-Martin","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"5733","key":"10.1016\/j.ibneur.2024.11.005_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ibneur.2024.11.005_bib43","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.neurobiolaging.2015.04.002","article-title":"Acyl-coenzyme A: cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage","volume":"36","author":"Shibuya","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.ibneur.2024.11.005_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/1873-3468.12907","article-title":"Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux","volume":"592","author":"Taleski","year":"2018","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.ibneur.2024.11.005_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009819","article-title":"Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines","volume":"5","author":"Tizon","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ibneur.2024.11.005_bib46","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/cb200292c","article-title":"A multifunctional protease inhibitor to regulate endolysosomal function","volume":"6","author":"van Kasteren","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neurobiolaging.2014.07.035","article-title":"Cross talk between PI3K-AKT-GSK-3beta and PP2A pathways determines tau hyperphosphorylation.","volume":"36","author":"Wang","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.ibneur.2024.11.005_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41398-022-02004-x","article-title":"OPTN attenuates the neurotoxicity of abnormal Tau protein by restoring autophagy","volume":"12","author":"Xu","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"Pt B)","key":"10.1016\/j.ibneur.2024.11.005_bib50","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2015.05.036","article-title":"Oxidative stress response and Nrf2 signaling in aging","volume":"88","author":"Zhang","year":"2015","journal-title":"Free Radic. Biol. Med."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242124000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242124000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:46:02Z","timestamp":1734597962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242124000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"alternative-id":["S2667242124000976"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2024.11.005","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer\u2019s diseases","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}